An Open-label Phase II Study of Weekly Intravenous Hycamtin and Carboplatin as First-line Treatment of Chemonaive Subjects With Extensive Disease Small Cell Lung Cancer.
Phase of Trial: Phase II
Latest Information Update: 12 May 2015
At a glance
- Drugs Carboplatin; Topotecan
- Indications Small cell lung cancer
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 06 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Oct 2009 Actual end date (May 2008) added as reported by ClinicalTrials.gov.
- 09 Jun 2008 Status changed from recruiting to in progress as reported by ClinicalTrials.gov.